Published in Gene Therapy Weekly, May 5th, 1997
Ovarian carcinoma has an extremely low five year survival rate. This is due largely to the advanced state of the disease in most women at the time of diagnosis. Unfortunately, there are not any early diagnostic tests currently available; new and more effective treatment protocols are desperately needed.
To this end, I. Chung and colleagues from the Yale University School of Medicine, Connecticut, and the New York...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.